- Home
- DKL vs ALVO Comparison
DKL vs ALVO Comparison
Compare DKL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKL
- ALVO
- Stock Information
- Founded
- DKL 2012
- ALVO 2013
- Country
- DKL United States
- ALVO Luxembourg
- Employees
- DKL N/A
- ALVO N/A
- Industry
- DKL Natural Gas Distribution
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- DKL Energy
- ALVO Health Care
- Exchange
- DKL Nasdaq
- ALVO Nasdaq
- Market Cap
- DKL 2.2B
- ALVO 2.5B
- IPO Year
- DKL N/A
- ALVO N/A
- Fundamental
- Price
- DKL $42.04
- ALVO $10.28
- Analyst Decision
- DKL Buy
- ALVO Buy
- Analyst Count
- DKL 4
- ALVO 1
- Target Price
- DKL $44.25
- ALVO $18.00
- AVG Volume (30 Days)
- DKL 188.7K
- ALVO 234.1K
- Earning Date
- DKL 05-07-2025
- ALVO 05-07-2025
- Dividend Yield
- DKL 10.46%
- ALVO N/A
- EPS Growth
- DKL 7.97
- ALVO N/A
- EPS
- DKL 2.98
- ALVO 0.34
- Revenue
- DKL $938,491,000.00
- ALVO $587,890,000.00
- Revenue This Year
- DKL $4.01
- ALVO $22.17
- Revenue Next Year
- DKL $4.46
- ALVO $58.38
- P/E Ratio
- DKL $14.13
- ALVO $30.33
- Revenue Growth
- DKL N/A
- ALVO 413.92
- 52 Week Low
- DKL $34.59
- ALVO $7.35
- 52 Week High
- DKL $45.71
- ALVO $14.65
- Technical
- Relative Strength Index (RSI)
- DKL 61.49
- ALVO 60.33
- Support Level
- DKL $40.10
- ALVO $9.60
- Resistance Level
- DKL $41.70
- ALVO $10.81
- Average True Range (ATR)
- DKL 0.97
- ALVO 0.51
- MACD
- DKL 0.30
- ALVO 0.12
- Stochastic Oscillator
- DKL 98.27
- ALVO 81.79
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.